World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
38800
World Ranking
6797
National Ranking
3589

Overview

Richard J. Jones is affiliated with Johns Hopkins University in the United States. Their research primarily centers on medicine, with a significant focus on hematology, genetics, oncology, public health, environmental and occupational health, and immunology.

Their work addresses key topics including hematopoietic stem cell transplantation, acute myeloid leukemia research, acute lymphoblastic leukemia research, myeloproliferative neoplasms: diagnosis and treatment, chronic myeloid leukemia treatments, polyomavirus and related diseases, and renal transplantation outcomes and treatments.

Among the frequent venues where Richard J. Jones publishes are:

  • Blood
  • Transplantation and Cellular Therapy
  • Blood Advances
  • Journal of Clinical Oncology
  • Leukemia & lymphoma/Leukemia and lymphoma

Frequent coauthors include:

  • Amy E. DeZern
  • Javier Bolaños-Meade
  • Ravi Varadhan
  • Richard F. Ambinder
  • Mark J. Levis

Notable recent publications by Richard J. Jones include:

  • Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis (2023), New England Journal of Medicine
  • Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial (2020), Blood
  • Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide (2020), Blood Advances
  • Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 (2024), Journal of Clinical Oncology
  • Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide (2021), Blood Advances

Best Publications

  • HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    Leo Luznik;Paul V. O'Donnell;Paul V. O'Donnell;Heather J. Symons;Allen R. Chen

  • Venoocclusive disease of the liver following bone marrow transplantation

    Richard J. Jones;Kamthorn S. K. Lee;William E. Beschorner;Victor G. Vogel

  • Characterization of clonogenic multiple myeloma cells

    William H Matsui;Carol Ann Huff;Qiuju Wang;Matthew T Malehorn

  • Cyclophosphamide and cancer: golden anniversary.

    Ashkan Emadi;Richard J. Jones;Robert A. Brodsky

  • Decreased erythropoietin response in patients with the anemia of cancer.

    Carole B. Miller;Richard J. Jones;Steven Piantadosi;Martin D. Abeloff

  • Inhibition of apoptosis during development of colorectal cancer.

    Atul Bedi;Pankaj J. Pasricha;Adil J. Akhtar;James P. Barber

  • Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia

    Atul Bedi;Barbara A. Zehnbauer;James P. Barber;Saul J. Sharkis

  • Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance

    William Matsui;Qiuju Wang;James P. Barber;Sarah Brennan

  • Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide

    P.V O'Donnell;L Luznik;R.J Jones;G.B Vogelsang

  • Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells

    Richard J. Jones;John E. Wagner;Paul Celano;Milada S. Zicha

  • Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.

    Eric K. Rowinsky;Ross C. Donehower;Richard J. Jones;Robert W. Tucker

  • Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

    Louise B. Grochow;Richard J. Jones;Robert B. Brundrett;Hayden G. Braine

  • BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents

    Atul Bedi;James P. Barber;Gauri C. Bedi;Wafik S. El-Deiry

  • High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

    Leo Luznik;Javier Bolaños-Meade;Marianna Zahurak;Allen R. Chen

  • HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

    Javier Bolaños-Meade;Ephraim J. Fuchs;Leo Luznik;Sophie M. Lanzkron

  • Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation.

    Richard J. Jones;Richard F. Ambinder;Steven Piantadosi;George W. Santos

  • Assessment of aldehyde dehydrogenase in viable cells

    R J Jones;J P Barber;M S Vala;M I Collector

  • Association of Foxp3 regulatory gene expression with graft-versus-host disease

    Yuji Miura;Christopher J. Thoburn;Emilie C. Bright;Michele L. Phelps

  • Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia

    Robert Iannone;James F Casella;Ephraim J Fuchs;Allen R Chen

  • Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation.

    Atul Bedi;Carole B. Miller;Janet L. Hanson;Steven Goodman

Frequent Co-Authors

Ephraim J. Fuchs
Ephraim J. Fuchs Johns Hopkins University
Richard F. Ambinder
Richard F. Ambinder Johns Hopkins University
Leo Luznik
Leo Luznik Johns Hopkins University
B. Douglas Smith
B. Douglas Smith Johns Hopkins University
Marianna Zahurak
Marianna Zahurak Johns Hopkins University
Georgia Boyce Vogelsang
Georgia Boyce Vogelsang Johns Hopkins University
Mark J. Levis
Mark J. Levis Johns Hopkins University
James Barber
James Barber Imperial College London
Saul J. Sharkis
Saul J. Sharkis Johns Hopkins University School of Medicine
Constance A. Griffin
Constance A. Griffin Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a doctor or surgeon. There are numerous related fields offering rewarding opportunities through accessible and flexible online education options. Many students are now considering roles like medical coding, nursing, and advanced practice nursing, which have become more attainable thanks to a variety of affordable online programs.

If you’re interested in healthcare administration, learning how much does it cost to become a medical coder can help you understand the financial investment required to gain these valuable skills. For registered nurses looking to advance their careers, bridging programs such as the cheapest rn to bsn online offer flexible pathways to a bachelor’s degree.

Those aiming for higher clinical positions may find the cheapest nurse practitioner programs appealing. For nurses interested in academia or research, an online phd in nursing can open doors to leadership roles and advanced scholarship in the field.

Exploring these related online degrees and career pathways ensures that aspiring healthcare professionals have diverse, affordable options to achieve their educational and professional goals in the USA.

Best Scientists Citing Richard J. Jones

Trending Scientists

Recently Published Articles